Patients' reluctance to undergo deep brain stimulation for Parkinson's disease

Abstract Background Many patients with advanced Parkinson's disease (PD) are reluctant to undergo the subthalamic nucleus deep brain stimulation (STN-DBS) when surgery is warranted. Reasons for this reluctance have not been examined. We undertook to establish the rate and causes of this relucta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Parkinsonism & related disorders 2016-02, Vol.23, p.91-94
Hauptverfasser: Kim, Mi-Ryoung, Yun, Ji Young, Jeon, Beomseok, Lim, Yong Hoon, Kim, Kyung Ran, Yang, Hui-Jun, Paek, Sun Ha
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 94
container_issue
container_start_page 91
container_title Parkinsonism & related disorders
container_volume 23
creator Kim, Mi-Ryoung
Yun, Ji Young
Jeon, Beomseok
Lim, Yong Hoon
Kim, Kyung Ran
Yang, Hui-Jun
Paek, Sun Ha
description Abstract Background Many patients with advanced Parkinson's disease (PD) are reluctant to undergo the subthalamic nucleus deep brain stimulation (STN-DBS) when surgery is warranted. Reasons for this reluctance have not been examined. We undertook to establish the rate and causes of this reluctance for STN-DBS in patients with advanced PD. Methods A reluctant group was defined as patients who were hesitant to undergo DBS. Clinical information included age, onset age, disease duration, the Unified Parkinson Disease Rating Scale, Hoehn and Yahr stage and levodopa equivalent dose when they were evaluated with a view to consider surgery. Results We enrolled 186 patients who underwent STN-DBS. 84 patients (45%) belonged to the reluctant group. Between the reluctant and the non-reluctant, there were no differences in preoperative characteristics. Main reasons for hesitation were fear of complications (74%) and economic burden (50%). The main reasons that they finally underwent the DBS were confidence in the doctor's decision (80%) and encouragement from their family (36%). Conclusions Building trust between patients and physicians is an important factor in guiding patients to undergo this treatment. To reduce the reluctance to undergo DBS at the appropriate time, we need to find effective ways of reducing their psychological and economic burden.
doi_str_mv 10.1016/j.parkreldis.2015.11.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1768578643</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S135380201530033X</els_id><sourcerecordid>1760892283</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-4c4923a2510cf256dbd455f4a451d9a068b5200c04951cba5233f5e3dee2b0843</originalsourceid><addsrcrecordid>eNqNks2KFDEUhYMozo--gmQ3bqq8-e30RtBBHWHQARXchVRyS9JTnbRJlTBvb4oeFVzNKll899zDlxBCGfQMmH616w-u3BacQqw9B6Z6xnpg8IicMrMRnWJcP253oURngMMJOat1BwAbBeIpOeFaG801nJJPN26OmOZ6QVvc4meXPNI50yUFLD8yDYgHOhQXE61z3C9T43OiYy70pnWIqeZ0UWkrgq7iM_JkdFPF5_fnOfn2_t3Xy6vu-vOHj5dvrjsvNZ876eWWC8cVAz9ypcMQpFKjdFKxsHWgzaA4gAe5VcwPTnEhRoWileEDGCnOyctj7qHknwvW2e5j9ThNLmFeqmUbbdTGaCkegoLZcm5W1BxRX3KtBUd7KHHvyp1lYFfxdmf_ibereMuYbeLb6Iv7Lcuwx_B38I_pBrw9Ati0_IpYbPVNvMcQC_rZhhwfsuX1fyF-iil6N93iHdZdXkpq2i2zlVuwX9YPsL4_UwJAiO_iN2tjrac</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1760892283</pqid></control><display><type>article</type><title>Patients' reluctance to undergo deep brain stimulation for Parkinson's disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kim, Mi-Ryoung ; Yun, Ji Young ; Jeon, Beomseok ; Lim, Yong Hoon ; Kim, Kyung Ran ; Yang, Hui-Jun ; Paek, Sun Ha</creator><creatorcontrib>Kim, Mi-Ryoung ; Yun, Ji Young ; Jeon, Beomseok ; Lim, Yong Hoon ; Kim, Kyung Ran ; Yang, Hui-Jun ; Paek, Sun Ha</creatorcontrib><description>Abstract Background Many patients with advanced Parkinson's disease (PD) are reluctant to undergo the subthalamic nucleus deep brain stimulation (STN-DBS) when surgery is warranted. Reasons for this reluctance have not been examined. We undertook to establish the rate and causes of this reluctance for STN-DBS in patients with advanced PD. Methods A reluctant group was defined as patients who were hesitant to undergo DBS. Clinical information included age, onset age, disease duration, the Unified Parkinson Disease Rating Scale, Hoehn and Yahr stage and levodopa equivalent dose when they were evaluated with a view to consider surgery. Results We enrolled 186 patients who underwent STN-DBS. 84 patients (45%) belonged to the reluctant group. Between the reluctant and the non-reluctant, there were no differences in preoperative characteristics. Main reasons for hesitation were fear of complications (74%) and economic burden (50%). The main reasons that they finally underwent the DBS were confidence in the doctor's decision (80%) and encouragement from their family (36%). Conclusions Building trust between patients and physicians is an important factor in guiding patients to undergo this treatment. To reduce the reluctance to undergo DBS at the appropriate time, we need to find effective ways of reducing their psychological and economic burden.</description><identifier>ISSN: 1353-8020</identifier><identifier>EISSN: 1873-5126</identifier><identifier>DOI: 10.1016/j.parkreldis.2015.11.010</identifier><identifier>PMID: 26686260</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Cost of Illness ; Deep brain stimulation ; Deep Brain Stimulation - economics ; Fear ; Female ; Humans ; Male ; Middle Aged ; Motor control ; Neurology ; Parkinson Disease - therapy ; Parkinson's disease ; Patient Acceptance of Health Care - psychology ; Patient Acceptance of Health Care - statistics &amp; numerical data</subject><ispartof>Parkinsonism &amp; related disorders, 2016-02, Vol.23, p.91-94</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-4c4923a2510cf256dbd455f4a451d9a068b5200c04951cba5233f5e3dee2b0843</citedby><cites>FETCH-LOGICAL-c462t-4c4923a2510cf256dbd455f4a451d9a068b5200c04951cba5233f5e3dee2b0843</cites><orcidid>0000-0003-3504-4612</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S135380201530033X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26686260$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Mi-Ryoung</creatorcontrib><creatorcontrib>Yun, Ji Young</creatorcontrib><creatorcontrib>Jeon, Beomseok</creatorcontrib><creatorcontrib>Lim, Yong Hoon</creatorcontrib><creatorcontrib>Kim, Kyung Ran</creatorcontrib><creatorcontrib>Yang, Hui-Jun</creatorcontrib><creatorcontrib>Paek, Sun Ha</creatorcontrib><title>Patients' reluctance to undergo deep brain stimulation for Parkinson's disease</title><title>Parkinsonism &amp; related disorders</title><addtitle>Parkinsonism Relat Disord</addtitle><description>Abstract Background Many patients with advanced Parkinson's disease (PD) are reluctant to undergo the subthalamic nucleus deep brain stimulation (STN-DBS) when surgery is warranted. Reasons for this reluctance have not been examined. We undertook to establish the rate and causes of this reluctance for STN-DBS in patients with advanced PD. Methods A reluctant group was defined as patients who were hesitant to undergo DBS. Clinical information included age, onset age, disease duration, the Unified Parkinson Disease Rating Scale, Hoehn and Yahr stage and levodopa equivalent dose when they were evaluated with a view to consider surgery. Results We enrolled 186 patients who underwent STN-DBS. 84 patients (45%) belonged to the reluctant group. Between the reluctant and the non-reluctant, there were no differences in preoperative characteristics. Main reasons for hesitation were fear of complications (74%) and economic burden (50%). The main reasons that they finally underwent the DBS were confidence in the doctor's decision (80%) and encouragement from their family (36%). Conclusions Building trust between patients and physicians is an important factor in guiding patients to undergo this treatment. To reduce the reluctance to undergo DBS at the appropriate time, we need to find effective ways of reducing their psychological and economic burden.</description><subject>Adult</subject><subject>Aged</subject><subject>Cost of Illness</subject><subject>Deep brain stimulation</subject><subject>Deep Brain Stimulation - economics</subject><subject>Fear</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Motor control</subject><subject>Neurology</subject><subject>Parkinson Disease - therapy</subject><subject>Parkinson's disease</subject><subject>Patient Acceptance of Health Care - psychology</subject><subject>Patient Acceptance of Health Care - statistics &amp; numerical data</subject><issn>1353-8020</issn><issn>1873-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks2KFDEUhYMozo--gmQ3bqq8-e30RtBBHWHQARXchVRyS9JTnbRJlTBvb4oeFVzNKll899zDlxBCGfQMmH616w-u3BacQqw9B6Z6xnpg8IicMrMRnWJcP253oURngMMJOat1BwAbBeIpOeFaG801nJJPN26OmOZ6QVvc4meXPNI50yUFLD8yDYgHOhQXE61z3C9T43OiYy70pnWIqeZ0UWkrgq7iM_JkdFPF5_fnOfn2_t3Xy6vu-vOHj5dvrjsvNZ876eWWC8cVAz9ypcMQpFKjdFKxsHWgzaA4gAe5VcwPTnEhRoWileEDGCnOyctj7qHknwvW2e5j9ThNLmFeqmUbbdTGaCkegoLZcm5W1BxRX3KtBUd7KHHvyp1lYFfxdmf_ibereMuYbeLb6Iv7Lcuwx_B38I_pBrw9Ati0_IpYbPVNvMcQC_rZhhwfsuX1fyF-iil6N93iHdZdXkpq2i2zlVuwX9YPsL4_UwJAiO_iN2tjrac</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Kim, Mi-Ryoung</creator><creator>Yun, Ji Young</creator><creator>Jeon, Beomseok</creator><creator>Lim, Yong Hoon</creator><creator>Kim, Kyung Ran</creator><creator>Yang, Hui-Jun</creator><creator>Paek, Sun Ha</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><orcidid>https://orcid.org/0000-0003-3504-4612</orcidid></search><sort><creationdate>20160201</creationdate><title>Patients' reluctance to undergo deep brain stimulation for Parkinson's disease</title><author>Kim, Mi-Ryoung ; Yun, Ji Young ; Jeon, Beomseok ; Lim, Yong Hoon ; Kim, Kyung Ran ; Yang, Hui-Jun ; Paek, Sun Ha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-4c4923a2510cf256dbd455f4a451d9a068b5200c04951cba5233f5e3dee2b0843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cost of Illness</topic><topic>Deep brain stimulation</topic><topic>Deep Brain Stimulation - economics</topic><topic>Fear</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Motor control</topic><topic>Neurology</topic><topic>Parkinson Disease - therapy</topic><topic>Parkinson's disease</topic><topic>Patient Acceptance of Health Care - psychology</topic><topic>Patient Acceptance of Health Care - statistics &amp; numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Mi-Ryoung</creatorcontrib><creatorcontrib>Yun, Ji Young</creatorcontrib><creatorcontrib>Jeon, Beomseok</creatorcontrib><creatorcontrib>Lim, Yong Hoon</creatorcontrib><creatorcontrib>Kim, Kyung Ran</creatorcontrib><creatorcontrib>Yang, Hui-Jun</creatorcontrib><creatorcontrib>Paek, Sun Ha</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Parkinsonism &amp; related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Mi-Ryoung</au><au>Yun, Ji Young</au><au>Jeon, Beomseok</au><au>Lim, Yong Hoon</au><au>Kim, Kyung Ran</au><au>Yang, Hui-Jun</au><au>Paek, Sun Ha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patients' reluctance to undergo deep brain stimulation for Parkinson's disease</atitle><jtitle>Parkinsonism &amp; related disorders</jtitle><addtitle>Parkinsonism Relat Disord</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>23</volume><spage>91</spage><epage>94</epage><pages>91-94</pages><issn>1353-8020</issn><eissn>1873-5126</eissn><abstract>Abstract Background Many patients with advanced Parkinson's disease (PD) are reluctant to undergo the subthalamic nucleus deep brain stimulation (STN-DBS) when surgery is warranted. Reasons for this reluctance have not been examined. We undertook to establish the rate and causes of this reluctance for STN-DBS in patients with advanced PD. Methods A reluctant group was defined as patients who were hesitant to undergo DBS. Clinical information included age, onset age, disease duration, the Unified Parkinson Disease Rating Scale, Hoehn and Yahr stage and levodopa equivalent dose when they were evaluated with a view to consider surgery. Results We enrolled 186 patients who underwent STN-DBS. 84 patients (45%) belonged to the reluctant group. Between the reluctant and the non-reluctant, there were no differences in preoperative characteristics. Main reasons for hesitation were fear of complications (74%) and economic burden (50%). The main reasons that they finally underwent the DBS were confidence in the doctor's decision (80%) and encouragement from their family (36%). Conclusions Building trust between patients and physicians is an important factor in guiding patients to undergo this treatment. To reduce the reluctance to undergo DBS at the appropriate time, we need to find effective ways of reducing their psychological and economic burden.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>26686260</pmid><doi>10.1016/j.parkreldis.2015.11.010</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-3504-4612</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1353-8020
ispartof Parkinsonism & related disorders, 2016-02, Vol.23, p.91-94
issn 1353-8020
1873-5126
language eng
recordid cdi_proquest_miscellaneous_1768578643
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Aged
Cost of Illness
Deep brain stimulation
Deep Brain Stimulation - economics
Fear
Female
Humans
Male
Middle Aged
Motor control
Neurology
Parkinson Disease - therapy
Parkinson's disease
Patient Acceptance of Health Care - psychology
Patient Acceptance of Health Care - statistics & numerical data
title Patients' reluctance to undergo deep brain stimulation for Parkinson's disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T02%3A34%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patients'%20reluctance%20to%20undergo%20deep%20brain%20stimulation%20for%20Parkinson's%20disease&rft.jtitle=Parkinsonism%20&%20related%20disorders&rft.au=Kim,%20Mi-Ryoung&rft.date=2016-02-01&rft.volume=23&rft.spage=91&rft.epage=94&rft.pages=91-94&rft.issn=1353-8020&rft.eissn=1873-5126&rft_id=info:doi/10.1016/j.parkreldis.2015.11.010&rft_dat=%3Cproquest_cross%3E1760892283%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1760892283&rft_id=info:pmid/26686260&rft_els_id=1_s2_0_S135380201530033X&rfr_iscdi=true